Litigation Details for Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-04-24 |
| Court | District Court, D. Delaware | Date Terminated | 2020-09-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Both | Referred To | |
| Parties | SALIX PHARMACEUTICALS, INC. | ||
| Patents | 10,314,828; 10,335,397; 10,456,384; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 7,928,115; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,271,968; 9,421,195; 9,629,828 | ||
| Attorneys | Elizabeth E. Grden | ||
| Firms | Morris, Nichols, Arsht & Tunnell LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-26 | 1 | Complaint | United States Patent Nos. 7,045,620 (the “’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…infringe one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…to the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644 | External link to document |
| 2021-08-03 | 118 | the Invalidity of U.S. Patent Nos. 8,642,573; 8,969,398; 9,421,195; 10,335,397; and 10,709,694 4. Opening…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 2. Opening Expert of Michael J. Zaworotko…Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both | External link to document | |
| 2021-10-19 | 138 | Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 (3)…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 (7) Responsive Expert Report of Richard…Regarding Noninfringement of Claims 9 and 10 of U.S. Patent No. 7,906,542 filed by Norwich Pharmaceuticals … 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
